PM360 Online: 4 Biotech Executives Share Strategies Behind Successful Fund Raises

As Addimmune, a division of American Gene Technologies dedicated to developing a gene therapy to cure HIV, we understand the challenges and opportunities that come with fundraising in the biotech industry. This article explores the experiences of four different biotech companies and the strategies they used to secure funding. The report highlights that while overall…

Read More

Cell and Gene: Imagine A World Without HIV – Could Gene Therapy Deliver A Cure?

Addimmune, the HIV division of American Gene Technologies, believes that the time for transformative HIV treatment change is now. While antiretroviral therapies (ART) are effective, challenges remain with non-adherence and treatment failure leading to ongoing transmission risk for many patients. Why Gene and Cell Therapy? This modality has proven successful against other diseases. In HIV,…

Read More

Rockville biotech company aims to cure HIV

At Addimmune, we are excited to see this article highlighting the progress being made in the fight against HIV. As the article mentions, Addimmune, the HIV division of American Gene Technologies, is at the forefront of developing a gene and cell therapy to cure HIV. Our therapy focuses on modifying HIV-infected CD4 T cells to…

Read More